Skip to main content

Table 1 Patient characteristics and perioperative data

From: Analysis of risk factors for postoperative complications in non-small cell lung cancer: comparison with the Japanese National Clinical Database risk calculator

Variables

 

Sex (man / woman)

364 / 221

Age, medial, range (y)

69 (34–92)

Comorbidity

333 (56.9%)

Malignant disease

81 (13.8%)

Hypertension

92 (15.7%)

Diabetes mellitus

81 (13.8%)

Angina pectoris

37 (6.3%)

COPD

35 (5.9%)

Cerebral infarction

24 (4.1%)

Arrhythmia

20 (3.4%)

Interstitial lung disease

9 (1.5%)

Asthma

20 (3.4%)

Autoimmune disease

15 (2.5%)

Chronic renal failure

7 (1.1%)

Body mass index, median (range)

22.8 (14.3–36.6)

CEA, median, range (ng/ml)

3.4 (0.5–306)

Brinkman index, median (range)

600 (0–3600)

PNI, median (range)

50.0 (26.9–67.5)

NLR, median (range)

2.14 (0.66–12.65)

%VC, median (range)

111 (45.7–184.2)

FEV1%, median (range)

73.4 (30.5–99.5)

Lobe of lung cancer (RU / RM / RL / LU / LL)

179 / 37 / 137 / 139 / 93

pStage (0 / IA / IB / IIA / IIB / IIIA / IIIB / IV / yIA / yIIA)

32 / 284 / 107 / 43 / 57 / 51 / 3 / 2 / 5 / 1

Histological type (Ad / Sq / LCNEC / AdSq / Pleo / Large / Carci)

441 / 108 / 17 / 9 / 4 / 3 / 3

Operative approach (Open / VATS / RATS)

71 / 662 / 6

Location of Lobectomy (RU / RM / RL / LU / LL)

175 / 36 / 106 / 108 / 76

Operative procedure (Seg / Lob / Lob + CW / Lob + Seg / Sleeve Lob / Bilob / Pneumo)

68 / 473 / 9 / 3 / 4 / 10 / 18

Morbidity

176 (30.0%)

Air leakage

81 (13.8%)

Arrhythmia

44 (7.5%)

Atelectasis

19 (3.2%)

Pneumonia

12 (2.0%)

Attack of asthma

4 (0.6%)

Cerebral infarction

3 (0.5%)

Chylothorax

2 (0.3%)

Broncho-pleural fistula

2 (0.3%)

Clavien–Dindo grade (0 / I / II / IIIa / IIIb)

409 / 1 / 71 / 99 / 5

Mortality

1 (0.1%)

Mortality or severe morbidity

67 (11.4%)

Tracheal or bronchial fistula

2 (0.3%)

Respiratory disfunction

4 (0.6%)

NCD risk score

 

Mortality, median (range) (%)

0.2 (0–10.6)

Mortality or severe morbidity, median (range) (%)

4.6 (1–39.3)

Tracheal or bronchial fistula, median (range) (%)

0.2 (0–8.1)

Respiratory disfunction, median (range) (%)

0.2 (0–8.2)

  1. COPD chronic obstructive pulmonary disease, CEA carcinoembryonic antigen, PNI prognostic nutritional index, NLR neutrophil-to-lymphocyte ratio, VC vital capacity, FEV1% forced expiratory volume % in one second, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower, p pathological, y yield to treatment, Ad adenocarcinoma, Sq squamous cell carcinoma, LCNEC large cell neuroendocrine carcinoma, AdSq adenosquamous cell carcinoma, Large large cell carcinoma, Carci carcinoid, Open open thoracotomy, VATS video-assisted thoracic surgery, RATS robotic-assisted thoracic surgery, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower, RU right upper, RM right middle, RL right lower, LU left upper, LL left lower, Seg segmentectomy, Lob lobectomy, CW chest wall resection, Bilob bi-lobectomy, Pneumo pneumonectomy, NCD national clinical database